Want to join the conversation?
$DHR posted sales of $2,679.5MM in its largest segment, Life Sciences & Diagnostics, in 4Q15, up 25.5% from 4Q14. Sales in the Test & Measurement segment declined 8.7% to $657.1MM. Environmental segment sales grew 0.91% to $997.5MM and Dental segment sales grew 17% to $734.6MM. Industrial Technologies sales fell 8.6% to $816.1MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?